The worlds #1 website for end of day & historical stock data
wide range of exchanges, data formats, tools and services
HISTORICAL DATA
SYMBOL LISTS
MEMBERSHIP
REGISTER
LOG IN
Toggle navigation
HOME
Home Page
Download
Symbol Lists
Quote & Chart
Symbol Changes
Splits
PRODUCTS & SERVICES
Membership Levels
Conversion Utility
Data Client
Historical Data
Fundamental Data
Commercial Feeds
Web Service
HOW TO
Advanced Get
AIQ
AMIBroker
EzyChart
MetaStock
OmniTrader
SuperCharts
TradeStation
SUPPORT
FAQ
Data Formats
Data Quality
Forgotten Password
Submit a Support Request
ABOUT
About Us
Contact Us
Terms & Conditions
Privacy Policy
Useful Links
MY ACCOUNT
Downloads
Account Details
Buy Historical Data
Billing History
Data Format
Daily Emails
Watchlists
NASDAQ, VRTX:
13 Aug 25 16:50
LAST:
395.9
CHANGE:
8.15
OPEN:
391.5
HIGH:
396.7
ASK:
170.0
VOLUME:
1.91M
CHG(%):
2.10
PREV:
387.8
LOW:
386.8
BID:
149.8
CHART
Period:
End of Day
1 Minute
5 Minute
10 Minute
15 Minute
30 Minute
Hourly
Weekly
Monthly
Yearly
RECENT END OF DAY PRICES
Date
Open
High
Low
Close
Volume
13 Aug 25
391.5
396.7
386.8
395.9
1.91M
12 Aug 25
377.6
388.3
375.0
387.8
2.04M
11 Aug 25
363.0
380.2
362.5
374.5
2.79M
08 Aug 25
377.0
381.0
364.7
366.5
3.68M
07 Aug 25
385.0
388.3
374.5
375.6
4M
06 Aug 25
375.8
390.6
372.4
385.7
4.73M
05 Aug 25
408.2
414.9
373.2
375.0
10.73M
04 Aug 25
466.5
473.4
462.1
472.3
2.33M
01 Aug 25
457.4
464.2
453.5
462.1
1.86M
31 Jul 25
465.3
470.6
455.5
456.9
1.48M
COMPANY PROFILE
Name:
About:
We are in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, our lead drug candidate, is an oral hepatitis C protease inhibitor and one of the most advanced of a new class of antiviral treatments in clinical development that target hepatitis C virus, or HCV, infection, a life-threatening disease. We expect to begin a Phase 3 clinical trial of telaprevir in March 2008 to evaluate 24-week telaprevir-based treatment regimens in treatment-na?ve patients with genotype 1 HCV. We have built a drug discovery capability that integrates biology, pharmacology, biophysics, chemistry, automation and information technologies in a coordinated manner, with the goal of more efficiently identifying promising drug candidates to address significant unmet medical needs. ...
Sector:
Consumer Durables
Industry:
Major Pharmaceuticals
CUSIP:
92532F100
CIK:
0875320
SYMBOL HISTORY
Purchase End of Day History
for this symbol from Jul 24, 1991
Purchase Intraday History
for this symbol from Jul 24, 1991
Add to Watchlist
ADD TO WATCHLIST
Please select which Watchlist you would like to add this symbol to:
Watchlist:
DOWNLOAD DATA
Download stock quote history quickly and easily in a variety of formats to suit your needs.
Exchange:
American Stock Exchange
Australian Securities Exchange
Chicago Futures Exchange
Cryptocurrencies
EUREX Futures Exchange
Euronext - Amsterdam
Euronext - Brussels
Euronext - Lisbon
Euronext - Oslo
Euronext - Paris
Foreign Exchange
Frankfurt Exchange
Global Indices
LIFFE Futures and Options
London Stock Exchange
Madrid Stock Exchange
Minneapolis Grain Exchange
Mutual Funds
NASDAQ Stock Exchange
National Stock Exchange of India
New York Board of Trade
New York Stock Exchange
OTC Bulletin Board
Shanghai Stock Exchange
Shenzhen Stock Exchange
Singapore Stock Exchange
Toronto Stock Exchange
Toronto Venture Exchange
Winnipeg Commodity Exchange
Format:
3F VIP Trading
Advanced Get ASCII
AGet ASCII
AIQ Trading Expert Pro
Ami Broker
Ami Broker with Names
Andromeda
ASCII (Intraday)
EzyCharts
FCharts
FCharts (Intraday)
MetaStock ASCII (7 column)
MetaStock ASCII (8 column)
Metastock ASCII (Intraday)
MetaStock ASCII with Names
Personal Stock Streamer
Quicken
SpiffyCharts
Spreadsheet (eg: Excel)
Standard CSV
Stock Screener Pro
SuperCharts ASCII
Wal Data Platinum
Windows on Wallstreet
Period:
End of Day
1 Minute Bars
5 Minute Bars
10 Minute Bars
15 Minute Bars
30 Minute Bars
60 Minute Bars
Zip file
Symbol:
Start Date:
End Date:
FUNDAMENTALS
P/E Ratio:
24.41
PEG Ratio:
1.22
EPS Ratio:
-3.81
PtB:
7.14
PtS:
17.01
EBITDA:
408.78M
Shares:
256.8M
Market Cap:
101.671B
52wk range:
362.50 - 519.88
TECHNICALS
MA5:
380.06
MA20:
436.06
MA50:
447.10
MA200:
459.73
STO9:
18.23
RSI14:
31.28
WPR14:
-72.21
MTM14:
-73.73
ROC14:
-0.16
Week High:
396.72
Week Low:
362.50
Month High:
480.00
Month Low:
362.50